Thomas Bartl

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Journal of personalized medicine

Cancers

Journal of gynecologic oncology

Medical University of Vienna

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Vienna

Austria

Resident :: Department of Obstetrics and Gynecology

Publications

Arina Onoprienko, Gerda Hofstetter, Leonhard Muellauer, Tim Dorittke, Stephan Polterauer, Christoph Grimm, Thomas Bartl
Prognostic role of transcription factor ARID1A in patients with endometrial cancer of no specific molecular profile (NSMP) subtype. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (6) (2024)
Arina Onoprienko, Gerda Hofstetter, Leonhard Muellauer, Tim Dorittke, Stephan Polterauer, Christoph Grimm, Thomas Bartl
Prognostic role of transcription factor ARID1A in patients with endometrial cancer of no specific molecular profile (NSMP) subtype. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (6) (2024)
Isabella Taglialatela, Paulina Reyes, Holli Nelson, Hunter McSpedden, Elizabeth Jacobi, Thomas Bartl, Pedro T Ramirez
Diagnostic management of endometrial cancer in a single horn of a bicornuate uterus. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Melina Danisch, Marlene Kranawetter, Thomas Bartl, Magdalena Postl, Christoph Grimm, Eva Langthaler, Stephan Polterauer
Oncologic and Obstetric Outcomes Following Radical Abdominal Trachelectomy in Non-Low-Risk Early-Stage Cervical Cancers: A 10-Year Austrian Single-Center Experience. Journal of personalized medicine 14 (6) (2024)
Arina Onoprienko, Gerda Hofstetter, Leonhard Muellauer, Tim Dorittke, Stephan Polterauer, Christoph Grimm, Thomas Bartl
Prognostic role of transcription factor ARID1A in patients with endometrial cancer of no specific molecular profile (NSMP) subtype. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Melina Danisch, Marlene Kranawetter, Thomas Bartl, Magdalena Postl, Christoph Grimm, Eva Langthaler, Stephan Polterauer
Oncologic and Obstetric Outcomes Following Radical Abdominal Trachelectomy in Non-Low-Risk Early-Stage Cervical Cancers: A 10-Year Austrian Single-Center Experience. Journal of personalized medicine 14 (6) (2024)
Thomas Bartl, Christoph Grimm, Robert M Mader, Christoph C Zielinski, Gerald Prager, Matthias Unseld, Merima Herac-Kornauth
Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer. Journal of personalized medicine 13 (8) (2023)
Thomas Bartl, Anita Alberts, Sofia-Christina Papadopoulos, Andrea Wolf, Leonhard Muellauer, Gerda Hofstetter, Christoph Grimm, Dan Cacsire Castillo-Tong
Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Thomas Bartl, Anita Alberts, Sofia-Christina Papadopoulos, Andrea Wolf, Leonhard Muellauer, Gerda Hofstetter, Christoph Grimm, Dan Cacsire Castillo-Tong
Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Thomas Bartl, Anita Alberts, Sofia-Christina Papadopoulos, Andrea Wolf, Leonhard Muellauer, Gerda Hofstetter, Christoph Grimm, Dan Cacsire Castillo-Tong
Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Arina Onoprienko, Gerda Hofstetter, Tim Dorittke, Christine Bekos, Christoph Grimm, Mariella Polterauer, Thomas Bartl, Stephan Polterauer
The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer. Journal of personalized medicine 12 (11) (2022)
Arina Onoprienko, Gerda Hofstetter, Tim Dorittke, Christine Bekos, Christoph Grimm, Mariella Polterauer, Thomas Bartl, Stephan Polterauer
The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer. Journal of personalized medicine 12 (11) (2022)
Arina Onoprienko, Gerda Hofstetter, Tim Dorittke, Christine Bekos, Christoph Grimm, Mariella Polterauer, Thomas Bartl, Stephan Polterauer
The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer. Journal of personalized medicine 12 (11) (2022)
Thomas Bartl, Florian Wolf, Christian Dadak
Pelvic congestion syndrome (PCS) as a pathology of postmenopausal women: a case report with literature review. BMC women's health 21 (1) (2021)
Thomas Bartl, Arina Onoprienko, Gerda Hofstetter, Leonhard Müllauer, Nina Poetsch, Thorsten Fuereder, Paul Kofler, Stephan Polterauer, Christoph Grimm
Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients. Biomolecules 11 (11) (2021)
Thomas Bartl, Jasmine Karacs, Caroline Kreuzinger, Stephanie Pfaffinger, Jonatan Kendler, Cristina Ciocsirescu, Andrea Wolf, Alexander Reinthaller, Elias Meyer, Maximilian Brandstetter, Magdalena Postl, Eva Langthaler, Elena Braicu, Ignace Vergote, Paula Cunnea, Charlie Gourley, Wolfgang Daniel Schmitt, Dan Cacsire Castillo-Tong, Christoph Grimm
Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients. Cancers 13 (5) (2021)
Thomas Bartl, Christine Bekos, Magdalena Postl, Reinthaller Alexander, Stephan Polterauer, Stefanie Aust, Schwameis Richard
The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer. Journal of gynecologic oncology 32 (1) (2020)

Thomas Bartl.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Bartl